Studies in the plasma of breast cancer patients evaluated the association between plasmatic concentrations of carotenoids, retinol, tocopherol, and vitamin C and the risk of breast cancer, and found that higher concentrations of plasma β-carotene and α-carotene were related to lower breast cancer risk in HER2 tumors [132]. This evidence concerns the gene ERBB2 and breast carcinoma.